Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Malignancy in Common Variable Immunodeficiency: A Systematic Review and Meta-Analysis Publisher Pubmed



Kiaee F1, 2 ; Azizi G3 ; Rafiemanesh H4 ; Zainaldain H2 ; Sadaat Rizvi F2 ; Alizadeh M5, 6 ; Jamee M6 ; Mohammadi S2 ; Habibi S2 ; Sharifi L7 ; Jadidiniaragh F8, 9 ; Haghi S10 ; Yazdani R2 ; Abolhassani H2, 11 Show All Authors
Authors
  1. Kiaee F1, 2
  2. Azizi G3
  3. Rafiemanesh H4
  4. Zainaldain H2
  5. Sadaat Rizvi F2
  6. Alizadeh M5, 6
  7. Jamee M6
  8. Mohammadi S2
  9. Habibi S2
  10. Sharifi L7
  11. Jadidiniaragh F8, 9
  12. Haghi S10
  13. Yazdani R2
  14. Abolhassani H2, 11
  15. Aghamohammadi A2
Show Affiliations
Authors Affiliations
  1. 1. Department of Immunology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  2. 2. Research Center for Immunodeficiencies, Children’s Medical Center, Tehran University of Medical Sciences, Tehran, Iran
  3. 3. Non-communicable Diseases Research Center, Alborz University of Medical Sciences, Karaj, Iran
  4. 4. Student Research Committee, Department of Epidemiology, School of Public Health, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  5. 5. Evidence- Based Phytotherapy and Complementary Medicine Research Center, Alborz University of Medical Sciences, Karaj, Iran
  6. 6. Student Research Committee, Alborz University of Medical Sciences, Karaj, Iran
  7. 7. Uro-Oncology Research Center, Tehran University of Medical Sciences, Tehran, Iran
  8. 8. Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
  9. 9. Department of Immunology, School of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran
  10. 10. Department of Hematology & Oncology, School of Medicine, Alborz University of Medical Sciences, Karaj, Iran
  11. 11. Division of Clinical Immunology, Department of Laboratory Medicine, Karolinska Institute at Karolinska University Hospital Huddinge, Stockholm, Sweden

Source: Expert Review of Clinical Immunology Published:2019


Abstract

Background: Common variable immunodeficiency (CVID) is the most common clinically significant primary immunodeficiency (PID) disorder characterized by variable clinical manifestations including recurrent infections, autoimmune disorders, enteropathy, lymphoproliferative disorders, and malignancy. The aim of this study is to estimate the overall prevalence of malignancy in patients with CVID. Methods: PubMed, Web of Science and Scopus were searched systemically to find eligible studies from the earliest available date to March 2019 with standard keywords. Pooled estimates of the malignancy prevalence and the corresponding 95% confidence intervals (CI) were calculated using random effects models. Results: Forty-eight studies with a total of 8123 CVID patients met the inclusion criteria and were finally included in the meta-analysis. Overall prevalence of malignancy was 8.6% (95% CI: 7.1–10.0; I2 = 79.2%). The prevalence of lymphoma, gastric cancer, and breast cancer in CVID patients were 4.1% (95% CI: 3.3–4.9; I2 = 62.6%), 1.5% (95% CI: 0.78–2.2; I2 = 68.9%), and 1.3% (95% CI: 0.64–1.9; I2 = 54.9%), respectively. Moreover, autoimmunity and malabsorption were more frequent in patients with malignancy than those without malignancy. Conclusion: The prevalence of malignancy has increased in CVID patients due to recent improvement in survival rate and the lymphoma is the most common type. This research highlighted the significance of malignancy screening and management in CVID patients. © 2019, © 2019 Informa UK Limited, trading as Taylor & Francis Group.
Other Related Docs
9. Inborn Errors of Immunity and Cancers, Cancer Immunology: A Translational Medicine Context# Second Edition (2020)
14. T-Cell Abnormalities in Common Variable Immunodeficiency, Journal of Investigational Allergology and Clinical Immunology (2016)
16. The Clinical and Immunological Features of Patients With Primary Antibody Deficiencies, Endocrine# Metabolic and Immune Disorders - Drug Targets (2018)
19. Role of Rare Immune Cells in Common Variable Immunodeficiency, Pediatric Allergy and Immunology (2022)
26. Primary Immunodeficiencies and Cancers, Cancer Immunology: A Translational Medicine Context (2015)
27. Common Presentations and Diagnostic Approaches, Stiehm's Immune Deficiencies: Inborn Errors of Immunity (2020)
31. Application of Flow Cytometry in Predominantly Antibody Deficiencies, Endocrine# Metabolic and Immune Disorders - Drug Targets (2021)
32. Role of Apoptosis in the Pathogenesis of Common Variable Immunodeficiency (Cvid), Endocrine# Metabolic and Immune Disorders - Drug Targets (2017)
33. Pulmonary Manifestations of Predominantly Antibody Deficiencies, Pulmonary Manifestations of Primary Immunodeficiency Diseases (2018)
35. Infectious and Noninfectious Pulmonary Complications in Patients With Primary Immunodeficiency Disorders, Journal of Investigational Allergology and Clinical Immunology (2017)
41. Approach to the Management of Autoimmunity in Primary Immunodeficiency, Scandinavian Journal of Immunology (2017)
43. Autoimmunity in Primary Antibody Deficiencies, International Archives of Allergy and Immunology (2017)